Rentokil Initial Stock Earnings Reports

Key points for investors: Rentokil delivered modestly improved 2025 results with group revenue up 3.8% (organic +2.6%) and adjusted operating profit up 5.4% to just over $1bn, lifted by better H2 performance and early benefits from North America cost efficiencies. North America is the primary focus: organic growth recovered through the year (Pest Control Services Q4 organic +2.6%), lead flow rose (H2 +7%+), colleague retention improved, 150 small satellite branches were opened and $25m of in-year cost savings were realized. Management is revising the North America rollout to retain more regional/local brands (expanding planned supported brands to ~30), grow the small-branch network to ~220 satellites in 2026 (target ~800 total branches by year-end), simplify pay-plan harmonization (grandfathering option for existing technicians) and deploy a Branch 360 reporting layer to standardize visibility across legacy systems. The company expects to continue pursuing a $100m cost reduction program (ongoing through 2027) to underpin targets including North America net operating margins >20% by 2027. Cash generation was strong (free cash flow $615m, conversion 98%), net debt fell to $3.65bn (leverage 2.6x), the Board proposes a 3% higher dividend, and bolt-on M&A will continue (pipeline and ~$200m target for 2026). The termite litigation provision increased (additional $201m in 2025) with cash claim payments of $95m in 2025 and a similar expected cash outflow in 2026; management expects these payments to moderate over time but cannot precisely predict the pace. Management highlights expanding use of generative AI (Google Gemini rollout, PestConnect Optix, internal AI agents) to improve lead prioritization, technician tools and operational efficiency. Overall, the company is improving operationally, strengthening cashflow and balance sheet metrics, and has set out pragmatic, more incremental integration and growth steps in North America to restore and accelerate organic growth.